Clinical studies of cefpodoxime proxetil in pediatric field
Kimura, S.; Yokoyama, M.; Kudo, M.; Aoyama, R.; Okamoto, T.; Tsushima, N.; Onodera, N.; Ikeda, Y.
Japanese Journal of Antibiotics 42(7): 1477-1487
1989
ISSN/ISBN: 0368-2781 PMID: 2810724 Document Number: 336434
Clinical studies of cefpodoxime proxetil (CPDX-PR), a new cephem antibiotic, were carried out in 60 patients in the pediatric field. The overall efficacy rate on 54 patients with various infections was 98.1%, and few side effects, all of them very mild, were developed in 6 of 60 patients (10%). It was concluded that CPDX-PR was one of the most useful antibiotics in the pediatric field because of the high efficacy rate and the safety.